Unique ID issued by UMIN | UMIN000038883 |
---|---|
Receipt number | R000044259 |
Scientific Title | Study for Monitoring the Impact of National HPV vaccinaTion program in Japan( Period II: April 2019-December 2026) |
Date of disclosure of the study information | 2019/12/16 |
Last modified on | 2022/12/14 11:10:30 |
Study for Monitoring the Impact of National HPV vaccinaTion program in Japan( Period II : April 2019-December 2026)
Monitoring the Impact of National HPV vaccinaTion program in Japan (MINT study II )
Study for Monitoring the Impact of National HPV vaccinaTion program in Japan( Period II: April 2019-December 2026)
Monitoring the Impact of National HPV vaccinaTion program in Japan (MINT study II )
Japan |
Cervical cancer and its precursor lesions
Obstetrics and Gynecology |
Malignancy
NO
Monitoring the Impact of National HPV vaccination program in Japan
Efficacy
Confirmatory
Pragmatic
Not applicable
The proportion of HPV16/18 positives among subjects of
cervical cancer, CIN2/3 and AIS in women aged 16-24, and 25-29 years
1. The number of women aged 16-24, and 25-29 years who contract cervical cancer,CIN2/3, AIS
2. The proportion of HPV16/18 positives among subjects of CIN1 in women aged 16-24, and 25-29 years
3. The proportion of HPV16/18 positives among subjects of cervical cancer, CIN2/3 and AIS in women aged 16-39 years
4. The distribution of HPV types among subjects of cervical cancer, CIN1/2/3, and AIS in women aged 16-39 years
5. The number of women aged 16-39 years who contract cervical cancer, CIN2/3, and AIS
6. The proportion of HPV16/18 positives among women aged 16-39 years with CIN1
7. The number of deaths from cervical cancer among women aged 16-39 years
Observational
16 | years-old | <= |
40 | years-old | > |
Female
All females, aged 16-39 years, who are newly diagnosed with cervical cancer, CIN, or AIS and have not yet been treated
Individuals in either of the groups listed below will be excluded as subjects of the research
1. Female patients younger than 16 or older than 39 years
2. Female who do not have CIN, AIS or cervical cancer
4000
1st name | Koji |
Middle name | |
Last name | Matsumoto |
Showa University School of Medicine
Department of Obstetrics and Gynecology
142-8666
1-5-8 Hatanodai, Shinagawa-ku, Tokyo
03-3784-8551
matsumok@mui.biglobe.ne.jp
1st name | Yoshitaka |
Middle name | |
Last name | Yamaguchi |
Showa University School of Medicine
Ethics Comittee
142-8555
1-5-8 Hatanodai, Shinagawa-ku, Tokyo
03-3784-8129
m-rinri@ofc.showa-u.ac.jp
Showa University School of Medicine
Japan Agency for Medical Research and Dvelopment( AMED)
Japanese Governmental office
Showa University School of Medicine
1-5-8 Hatanodai, Shinagawa-ku, Tokyo
03-3784-8551
monuki@med.showa-u.ac.jp
YES
19fk0108098
Japan Agency for Medical Research and Dvelopment( AMED)
22fk0108651h0001
Japan Agency for Medical Research and Dvelopment( AMED)
2019 | Year | 12 | Month | 16 | Day |
Unpublished
Open public recruiting
2019 | Year | 04 | Month | 01 | Day |
2019 | Year | 07 | Month | 16 | Day |
2019 | Year | 07 | Month | 25 | Day |
2026 | Year | 12 | Month | 31 | Day |
Proactive long-term epidemiological joint research conducted at multiple facilities
2019 | Year | 12 | Month | 13 | Day |
2022 | Year | 12 | Month | 14 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044259
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |